Effects of Ciclesonide MDI 50mg/Day and 200mg/Day (Ex-Valve) Once-Daily on Growth in Children With Mild Persistent Asthma
Clinical trial NCT00270348 · COMPLETED
Trial details
- NCT number
- NCT00270348
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-12-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.